-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, the World Health Organization (WHO) updated its COVID-19 patient care guidelines to include interleukin-6 (IL-6) receptor inhibitors
The WHO press release stated that this is the first drug found to be effective against COVID-19 since the organization recommended corticosteroids in September 2020
Severe or critical COVID-19 patients often have an overreaction of the immune system, which is very harmful to the health of the patient
This data analysis shows that compared with standard treatment, the use of these drugs can reduce the chance of death by 13% in severe or critically ill patients
Note: The original text has been deleted
Reference materials:
[1] WHO recommends life-saving interleukin-6 receptor blockers for COVID-19 and urges producers to join efforts to rapidly increase access.
[2] Interleukin-6 Inhibitors.